1. Distinct gene expression patterns in a tamoxifen-sensitive human mammary carcinoma xenograft and its tamoxifen-resistant subline MaCa 3366/TAM
   Michael Becker et al, 2005, Molecular Cancer Therapeutics CrossRef
2. Tuberatolide B Suppresses Cancer Progression by Promoting ROS-Mediated Inhibition of STAT3 Signaling
   Youn Choi et al, 2017, Marine Drugs CrossRef
3. LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer
   Li Pan et al, 2020, Breast Cancer Research and Treatment CrossRef
4. Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer
   Matthew Kearney et al, 2021, Breast Cancer Research and Treatment CrossRef
5. EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes
   Claudia D. Andl et al, 2004, American Journal of Physiology-Gastrointestinal and Liver Physiology CrossRef
6. Epidermal Growth Factor Receptor-Mediated Activation of Stat3 during Multistage Skin Carcinogenesis
   Keith Syson Chan et al, 2004, Cancer Research CrossRef
7. A small-molecule compound identified through a cell-based screening inhibits JAK/STAT pathway signaling in human cancer cells
   Byung Hak Kim et al, 2008, Molecular Cancer Therapeutics CrossRef
8. Selective Inhibition of ErbB2-Overexpressing Breast Cancer In vivo by a Novel TAT-Based ErbB2-Targeting Signal Transducers and Activators of Transcription 3–Blocking Peptide
   Ming Tan et al, 2006, Cancer Research CrossRef